FI920720A7 - 4-pyrimidinonderivat, framstaellning av dessa och anvaendning av dessa iterapi - Google Patents

4-pyrimidinonderivat, framstaellning av dessa och anvaendning av dessa iterapi Download PDF

Info

Publication number
FI920720A7
FI920720A7 FI920720A FI920720A FI920720A7 FI 920720 A7 FI920720 A7 FI 920720A7 FI 920720 A FI920720 A FI 920720A FI 920720 A FI920720 A FI 920720A FI 920720 A7 FI920720 A7 FI 920720A7
Authority
FI
Finland
Prior art keywords
dessa
pyrimidinonderivat
iterapi
framstaellning
och anvaendning
Prior art date
Application number
FI920720A
Other languages
English (en)
Finnish (fi)
Other versions
FI920720A0 (fi
Inventor
Christian Hoornaert
Marc Daumas
Michel Aletru
Jean-Claude Muller
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI920720A0 publication Critical patent/FI920720A0/fi
Publication of FI920720A7 publication Critical patent/FI920720A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
FI920720A 1991-02-20 1992-02-19 4-pyrimidinonderivat, framstaellning av dessa och anvaendning av dessa iterapi FI920720A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9102032A FR2672892B1 (fr) 1991-02-20 1991-02-20 Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
FI920720A0 FI920720A0 (fi) 1992-02-19
FI920720A7 true FI920720A7 (fi) 1992-08-21

Family

ID=9409925

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920720A FI920720A7 (fi) 1991-02-20 1992-02-19 4-pyrimidinonderivat, framstaellning av dessa och anvaendning av dessa iterapi

Country Status (23)

Country Link
EP (1) EP0500409B1 (cs)
JP (1) JP2529798B2 (cs)
KR (1) KR920016434A (cs)
CN (1) CN1034171C (cs)
AT (1) ATE135695T1 (cs)
AU (1) AU650319B2 (cs)
CA (1) CA2061456A1 (cs)
CS (1) CS49092A3 (cs)
DE (1) DE69209113T2 (cs)
DK (1) DK0500409T3 (cs)
ES (1) ES2086090T3 (cs)
FI (1) FI920720A7 (cs)
FR (1) FR2672892B1 (cs)
GR (1) GR3019404T3 (cs)
HU (2) HUT60477A (cs)
IE (1) IE76145B1 (cs)
IL (1) IL101014A (cs)
MX (1) MX9200690A (cs)
NO (1) NO920648L (cs)
NZ (1) NZ241659A (cs)
PL (1) PL168617B1 (cs)
RU (1) RU2073675C1 (cs)
ZA (1) ZA921203B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
FR2700543B1 (fr) * 1993-01-15 1995-03-17 Synthelabo Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique.
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
UY32409A (es) 2009-01-30 2010-08-31 Takeda Pharmaceutical Compuesto de anillo fusionado y su uso
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
EP0479903B1 (en) * 1989-06-30 1996-02-21 E.I. Du Pont De Nemours And Company Substituted imidazoles useful as angiotensin ii blockers
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
EP0424317A3 (en) * 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
EP0522038A4 (en) * 1990-03-30 1993-05-26 Merck & Co. Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
IE912114A1 (en) * 1990-07-02 1992-01-15 Union Pharma Scient Appl Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present

Also Published As

Publication number Publication date
CA2061456A1 (en) 1992-08-21
CS49092A3 (en) 1992-09-16
CN1034171C (zh) 1997-03-05
ZA921203B (en) 1992-11-25
ATE135695T1 (de) 1996-04-15
NO920648D0 (no) 1992-02-19
MX9200690A (es) 1992-08-01
NZ241659A (en) 1993-03-26
HU211886A9 (en) 1995-12-28
DE69209113D1 (de) 1996-04-25
ES2086090T3 (es) 1996-06-16
DE69209113T2 (de) 1996-10-31
RU2073675C1 (ru) 1997-02-20
IL101014A (en) 1996-06-18
IL101014A0 (en) 1992-11-15
FR2672892B1 (fr) 1994-01-14
IE920525A1 (en) 1992-08-26
HU9200532D0 (en) 1992-05-28
NO920648L (no) 1992-08-21
JP2529798B2 (ja) 1996-09-04
PL168617B1 (pl) 1996-03-29
EP0500409A1 (fr) 1992-08-26
FI920720A0 (fi) 1992-02-19
IE76145B1 (en) 1997-10-08
DK0500409T3 (da) 1996-07-15
GR3019404T3 (en) 1996-06-30
CN1064269A (zh) 1992-09-09
HUT60477A (en) 1992-09-28
AU1105992A (en) 1992-08-27
JPH04346980A (ja) 1992-12-02
EP0500409B1 (fr) 1996-03-20
KR920016434A (ko) 1992-09-24
AU650319B2 (en) 1994-06-16
PL293531A1 (en) 1992-08-24
FR2672892A1 (fr) 1992-08-21

Similar Documents

Publication Publication Date Title
FI935421A7 (fi) Konstruktionsdel av plaot, byggnadspanel och byggnadsfoerfarande
FI935189A7 (fi) Glasfiberarmerad plastbehaollare, foerfarande och anordning foet tillverkning av en saodan behaollare
FI923143L (fi) Homogeniska, stabila och flytande vattenblandningar och anvaendning av naemnda blandningar foer framstaellning av dispersioner av i vatten oloesliga substanser
FI920465A0 (fi) Foerfarande foer elektrolytisk framstaellning av alkalimetallklorat och hjaelpkemikalier.
FI921866A0 (fi) Foerfarande foer framstaellning av laegre polyoler och blandningar daerav.
FI920732L (fi) 2-substituerade kinoliner, foerfarande foer framstaellning av dessa och anvaendning av dessa i laekemedel
FI920424A0 (fi) Foerfarande foer anvaendning av metalliseringsanlaeggning och anordning foer utfoerande av foerfarandet.
FI921284A0 (fi) Framstaellning av styva skum och komposition anvaendbar daeri.
FI924617A7 (fi) Anordning foer viktinstaellning av instaellning av sittyta och ryggstoed istolar, saerskilt byrosvaengstolar
FI914550A0 (fi) Foerfarande foer boejning och haerdning av bilars foenster.
FI923399A0 (fi) Foerfarande och anordning foer minskande av kvaeveoksidutslaepp av foerbraenningsmotorer.
FI923755L (fi) Disulfider, foerfarande foer framstaellning av dessa och anvaendning av dessa
FI920720A7 (fi) 4-pyrimidinonderivat, framstaellning av dessa och anvaendning av dessa iterapi
FI935845L (fi) Formskiva, kontaktskikt och foerfarande foer tillverkning av formskivan
FI910418A7 (fi) Foerfarande och anlaeggning foer klassificering av gas-fastsubstansstroemmen fraon en motstraolskvarn.
FI922139A0 (fi) Foerfarande och anordning foer framstaellning av anhydrit-stykgips.
FI910694A0 (fi) Foerfarande och anordning foer bevakning av tryckskillnad.
FI910881A0 (fi) Svetsningsinverter och foerfarande foer styrning av svetsningsinverter.
FI923204L (fi) Nedbrytbara karbonylhaltiga kelateringsmedel, anvaendning av dessa och kompositioner
FI924637L (fi) Foerfarande foer framstaellning av katalysatorer foer polymerisering av olefiner, katalysatorer erhaollna medelst detta foerfarande och foerfarandefoer polymerisering av olefiner i naervaro av dessa katalysatorer
FI910733A7 (fi) Foerfarande och anordningar foer plastbelaeggning av foderpaolar.
FI910590A0 (fi) Foerfarande och anordning foer loesgoerande av traedbark fraon en traedstam.
FI925740A7 (fi) Foerfarande foer smaeltning av silikatiska raomaterial, speciellt foer framstaellning av mineralull, och anordning foer foervaermning av en raomaterialblandning
FI920155L (fi) Foerfarande foer framstaellning av hydrolyserade proteiner och produkten daerav.
FI925974L (fi) Humant rotavirus-hcr3, nyorganiserade stammar av detta och vaccinkompositioner innehaollande dessa